Research & Publications
Dr. Hsieh is an Associate Professor of Medicine (Rheumatology) and Epidemiology (Chronic Diseases) at Yale, and Chief of Rheumatology for the VA Connecticut HealthCare System. She enjoys caring for patients and teaching on the medical wards of the West Haven VA Medical Center.
Dr. Hsieh is dedicated to bridging the fields of global health and rheumatology, in particular through research training. Her research combines biomedical and behavioral sciences approaches,and has leveraged national cohorts and international registries to better understand drivers of risk for osteoporosis, sarcopenia, and fracture among patients with chronic infection or inflammatory disease. A major focus of her work is on prevention, epidemiology and health services research for these musculoskeletal outcomes among individuals aging with HIV in countries undergoing economic transition (e.g., China and Peru) where incidence of these conditions is increasing, however infrastructure and capacity to diagnose and manage these comorbidities remains fragmented. The tools and models developed through this work have also translated to other low-resource settings and models of secondary osteoporosis (e.g., breast cancer and rheumatoid arthritis).
Dr. Hsieh also has a rich program of research at the VA, where she co-directs the Rheumatology, Endocrine and Geriatric Syndromes Core of the VA Family of EHR cohorts and is co-PI of an NIH-funded study to develop and validate a fracture risk prediction tool tailored for patients aging with HIV. This study leverages the outstanding infrastructure and team of the Veteran's Aging Cohort Study, the largest cohort of patients with HIV in the U.S., and partners with collaborators from Yale New Haven Healthcare System and BU/Boston Medical Center.
Finally, Dr. Hsieh is committed to mentoring research scholars through programs such as the Global Health Equity Scholars Program, the CMB Global Health Leadership Development Program, and the NIH T32 Training Program of the Yale Section of Rheumatology. Her research has been supported by the U.S. National Institutes of Health (Fogarty International Center, NIAMS, NIAAA, NCI, NIA, NCATS), Rheumatology Research Foundation, China Medical Board, and Doris Duke Charitable Foundation. She is co-founder and lead of the Yale Network for Global Non-Communicable Diseases, and was a 2018-2019 Fulbright Scholar. She is a past member of the Board of Directors of the American College of Rheumatology and currently chairs the ACR Global Engagement Committee.
Education & Training
- PhDYale Graduate School of Arts and Sciences, Investigative Medicine (Epidemiology & Global Health) (2014)
- Clinical & Research FellowYale School of Medicine (2014)
- ResidentYale-New Haven Hospital (2010)
- InternYale-New Haven Hospital (2008)
- MPHHarvard School of Public Health, Family and Community Health (2006)
- MDStony Brook University School of Medicine, Medicine (2006)
- ABPrinceton University, Molecular Biology (1999)
- Improving self-care among people with chronic conditions in UgandaNakaseke, Central Region, Uganda (2018-2020)Improving self-care among people with chronic conditions in Uganda
- Access to Training and Use of Muscuskeletal Ultrasound among Rheumatologists in ChinaBeijing, Beijing, China 2016Access to Training and Use of Muscuskeletal Ultrasound among Rheumatologists in China
- Osteoporosis Risk Factors, Knowledge and Health Beliefs among Women from a Peri-Urban Community in PeruLima, Lima, Peru 2015Osteoporosis Risk Factors, Knowledge and Health Beliefs among Women from a Peri-Urban Community in Peru
- Osteoporosis Among Individuals with HIV in ChinaBeijing, Beijing, China 2012These studies aim to measure and explore mechanisms associated with bone loss among Chinese individuals with human immunodeficiency viral after initiation of antiretroviral therapy (ART), with a special interest in tenofovir-based regimens which have been available first line in China since 2012. As well, we seek to explore behavioral factors, such as knowledge and health beliefs, that may influence risk for osteoporosis and fracture in this population.
- Vertebral Fractures Among Breast Cancer Survivors in ChinaBeijing, Beijing, China 2012The objective of this pilot study is to measure vertebral fracture prevalence, and explore knowledge and health beliefs surrounding osteoporosis among a cohort of Chinese breast cancer survivors compared with healthy age-matched controls.
Honors & Recognition
|U.S.-China Fulbright Scholar||U.S. Department of State||2018|
|Stony Brook 40 under Forty Alumni Award||Stony Brook University||2016|
|Distinguished Fellow Award||American College of Rheumatology||2013|
|Frederick L. Sachs Award||Yale Department of Internal Medicine||2010|
|Arnold J. Gold Humanism in Medicine Award||Stony Brook School of Medicine||2006|
|American College of Rheumatology||Chair, Global Engagement Committee||2021 - 2023|
|American College of Rheumatology||Member, Board of Directors||2017 - 2020|
|American College of Rheumatology||Government Affairs Committee||2016 - Present|
|American College of Rheumatology||Committee on Research||2016 - 2017|
|American College of Rheumatology||International Task Force||2014 - 2015|
|American College of Rheumatology||Curriculum Subcommittee, Committee on Training and Workforce||2013 - 2016|